Oral Combination Treatment of Gefitinib (Iressa<sup>TM</sup>) and Sasam-Kyeongokgo: Synergistic Effects on the NCI-H520 Tumor Cell Line

The aim of this research was to confirm the possible synergic effects of sasam-Kyeongokgo (SKOG) on the anti-tumor activity of gefitinib using athymic nude mice bearing the human non-small-cell lung squamous cell carcinoma (NSCLC) NCI-H520 cell line after continuous oral combination treatment provid...

Full description

Bibliographic Details
Published in:Applied Sciences
Main Authors: Jeong-Hoon Oh, Joo Wan Kim, Chul-Jong Jung, Jae-Suk Choi, Sae Kwang Ku
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Subjects:
sasam-Kyeongokgo
gefitinib
synergic effects
lung cancer
anti-tumor activity
carcinoma
Online Access:https://www.mdpi.com/2076-3417/13/2/1090

Internet

https://www.mdpi.com/2076-3417/13/2/1090

Similar Items